Yufeng Li

2.3k total citations
56 papers, 1.7k citations indexed

About

Yufeng Li is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Yufeng Li has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Epidemiology and 11 papers in Physiology. Recurrent topics in Yufeng Li's work include Liver Disease Diagnosis and Treatment (12 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Autophagy in Disease and Therapy (5 papers). Yufeng Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Autophagy in Disease and Therapy (5 papers). Yufeng Li collaborates with scholars based in China, Japan and United States. Yufeng Li's co-authors include Hiroyuki Sasaki, Dirk Schübeler, Sylvain Guibert, Hatsune Chiba, Julie Borgel, Thierry Forné, Michaël Weber, Yiqing Song, Ran Li and Wambui G. Gathirua‐Mwangi and has published in prestigious journals such as Nature Genetics, Cell Metabolism and Diabetes.

In The Last Decade

Yufeng Li

53 papers receiving 1.7k citations

Peers

Countries citing papers authored by Yufeng Li

Since Specialization

Citations

This map shows the geographic impact of Yufeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Li more than expected).

Fields of papers citing papers by Yufeng Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Li. The network helps show where Yufeng Li may publish in the future.

Co-authorship network of co-authors of Yufeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yufeng Li. A scholar is included among the top collaborators of Yufeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufeng Li. Yufeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antifreeze activity of soluble Antarctic krill proteins and their cryoprotective action against Lactobacillus bulgaricus 2025 ·Food Hydrocolloids ·S.-K. Tang, Lu Chen, Haiquan Liu, Yufeng Li, Yong Zhao, Jing Jing Wang	2
2	Novel antimicrobial polyvinyl alcohol film by incorporating β-cyclodextrin/berberine inclusion complex preserving the storage quality of salmon fillets 2024 ·Food Packaging and Shelf Life ·Lu Chen, Han Zhang, Shaojie Li, Yufeng Li, Yong Zhao, Qiaohui Zeng, Haiquan Liu, Jing Jing Wang	13
3	Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China 2024 ·Diabetes ·(unknown), (unknown), Zhifeng Cheng, Zhiyong Li, Hongwei� Jiang, Fang Zhang, Yufeng Li, Wei Qiu, Song Lu, Junhang Tian, (unknown), Fangqiong Li, Danqing Li	5
4	Polyethylene glycol loxenatide protects diabetic kidneys by inhibiting GRP78/PERK/eIF2α pathway, and improves cardiac injury by suppressing TLR4/NF-κB inflammatory pathway 2024 ·BMC Cardiovascular Disorders ·Chen Shi, Qilin Zhang, Yufeng Li, Junjun Zhao, Cong Wang, Yu Zhang	1
5	DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser ⁵⁶ to diminish pancreatic β cell function upon overnutrition 2024 ·Science Translational Medicine ·(unknown), Jun‐Yu Xu, Yufeng Li, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Qingqian Wu, (unknown), Zhuo‐Xian Meng, Minjia Tan, Jingya Li	12
6	Preparation of β-lactoglobulin-derived tryptophan peptide and its effect on anxiety-like behaviors in Zebrafish 2023 ·Frontiers in Nutrition ·Xiping Zhu, Dan Xie, (unknown), Yufeng Li, Chun Cui	2
7	Bioinformatics analysis and identification of genes and pathways involved in patients with Wilms tumor 2022 ·Translational Cancer Research ·Yufeng Li, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jian Pu, Di Yang	5
8	DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing 2021 ·Cell Metabolism ·Yufeng Li, Jun‐Yu Xu, Yuting Lu, Hua Bian, Lin Yang, (unknown), Xinwen Zhang, Beilei Zhang, (unknown), Yafei Chang, Jie Tang, Fan Yang, Lei Zhao, Jing Li, Xin Gao, Mingfeng Xia, Minjia Tan, (unknown), (unknown)	60
9	Inhibition of PDE1-B by Vinpocetine Regulates Microglial Exosomes and Polarization Through Enhancing Autophagic Flux for Neuroprotection Against Ischemic Stroke 2021 ·Frontiers in Cell and Developmental Biology ·Jiankun Zang, Yousheng Wu, (unknown), Tianyuan Zhang, (unknown), Dan Ma, Yufeng Li, (unknown), (unknown), (unknown), Chi Kwan Tsang, (unknown), Dan Lu	47
10	Novel glucose-lowering drugs for non-alcoholic fatty liver disease 2021 ·World Journal of Diabetes ·(unknown), Xiaoling Cai, Wenjia Yang, Mingming Zhao, Ran Li, Yufeng Li	22
11	Protective Effects and Mechanisms of Polyethylene Glycol Loxenatide Against Hyperglycemia and Liver Injury in db/db diabetic Mice 2021 ·Frontiers in Pharmacology ·Yu Zhang, Yufeng Li, Junjun Zhao, Cong Wang, Bin Deng, Qilin Zhang, (unknown)	10
12	Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits 2020 ·Magnetic Resonance Imaging ·Haifeng Liu, Qing Wang, Yanan Du, (unknown), Yufeng Li, (unknown), Wei Xing	7
13	Feasibility of T1 mapping with histogram analysis for the diagnosis and staging of liver fibrosis: Preclinical results 2020 ·Magnetic Resonance Imaging ·Qing Wang, Haifeng Liu, (unknown), Sheng Ye, Yanan Du, Yufeng Li, (unknown), (unknown), Wei Xing	5
14	The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population 2020 ·Metabolic Syndrome and Related Disorders ·Xiuying Zhang, Xianghai Zhou, Xueyao Han, (unknown), Lianying Wang, Yufeng Li, Linong Ji	1
15	Association between physical activity and abnormal glucose metabolism—A population-based cross-sectional study in China 2018 ·Journal of Diabetes and its Complications ·Ping Hu, Yufeng Li, Xianghai Zhou, Xiuying Zhang, Fang Zhang, Linong Ji	12
16	Sulfuretin protects hepatic cells through regulation of ROS levels and autophagic flux 2018 ·Acta Pharmacologica Sinica ·Yuting Lu, Yufeng Xiao, Yufeng Li, Jia Li, (unknown), Jingya Li	19
17	A novel splice site mutation of the PRKAR1A gene, C.440+5 G>C, in a Chinese family with Carney complex 2018 ·Journal of Endocrinological Investigation ·Jia Fu, Fan Lai, (unknown), Xia Wan, Guangyan Wei, Yufeng Li, Haipeng Xiao, Xiaopei Cao	2
18	Prevalence of and Risk Factors for Peripheral Neuropathy in Chinese Patients With Diabetes: A Multicenter Cross-Sectional Study 2018 ·Frontiers in Endocrinology ·Qi Pan, Quanmin Li, Wei Deng, Dong Zhao, Lin Qi, Wei Huang, Li Ma, Hongmei Li, Yufeng Li, (unknown), Aihong Wang, (unknown), Xiaoyan Xing, Lixin Guo	39
19	Targets and dynamics of promoter DNA methylation during early mouse development 2010 ·Nature Genetics ·Julie Borgel, Sylvain Guibert, Yufeng Li, Hatsune Chiba, Dirk Schübeler, Hiroyuki Sasaki, Thierry Forné, Michaël Weber	456
20	Eicosapentaenoic acid lowers plasma and liver cholesterol levels in the presence of peroxisome proliferators-activated receptor alpha 2008 ·Life Sciences ·Eiko Sugiyama, Yasuko Ishikawa, Yufeng Li, (unknown), (unknown), Naoki Tanaka, Yuji Kamijo, Shin Yokoyama, Atsushi Hara, Toshifumi Aoyama	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact